The Mental Health Crisis is not only a much larger pandemic than the Covid-19 pandemic. It is also much deadlier.

Researchers at the Pitt Graduate School of Public Health found that in the first half of 2017 California, Maine, Massachusetts, and Nevada all saw a 7.6% decline in opioid-related emergency room visits but that those rates returned to pre-legalization levels after the six months, according to a WESA outline of the study.

Yale scientists have found that a single dose of psilocybin given to mice induces a rapid and long-lasting increase in connections between pyramidal neurons in the medial frontal cortex, an area of the brain known to be involved in control and decision-making.

A new study suggests that cannabis was first domesticated in East Asia during the Neolithic Era—from 3900-1700 BC—and was a “multipurpose crop” likely used for both industrial and medical purposes.

Every 10 minutes, someone in the United States commits suicide — a suicide epidemic. Psychedelic drugs have the known potential to address and reverse this epidemic.

“Support the troops” the White House and Congress tell Americans, over and over. When will THEY start to support the troops? Psychedelic medicine would be a great place to start.

Numinus receives Health Canada approval to move forward with MAPS in its clinical testing for PTSD.

Psytech Inc is becoming a wholly-owned subsidiary of Wesana Health for an acquisition price of CAD$21 million in an all-share transaction.

Low doses of psilocybin and ketamine can heighten food-related motivation and improve attention in poorly-performing male rats, according to new research published in Frontiers in Pharmacology.